Trial intelligence / Profile preview

Magnesium-L-Threonate for Sleep Quality After Total Joint Arthroplasty

NCT06902285Phase 4Recruiting

Sponsor
University of Miami
Start
Apr 2025
Primary completion
Jul 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of Magnesium L-threonate in sleep disorder (2 arms), sponsored by University of Miami. Primary endpoints: Epworth Sleepiness Scale at 6 weeks and Pittsburgh Sleep Quality Index at 6 weeks. Started Apr 2025; status: recruiting.

02

Drugs

Magnesium L-threonate
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT06902285.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06902285.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call